Skip to content

CDR

London Drugs clinics to feature skin cholesterol test

Early next month, London Drugs aims to make available at all of its pharmacies a non-invasive cholesterol test that can help customers evaluate their risk for coronary artery disease (CAD) or heart disease. The western Canada drug chain said Thursday that on March 4 it plans to roll out the PreVu

GAO urged to review reimbursement cuts for diabetes supplies

The National Community Pharmacists Association has applauded lawmakers’ push for the Government Accountability Office (GAO) to review the impact of planned reductions in reimbursement for diabetes test supplies (DTS) provided to Medicare beneficiaries by community pharmacies. NCPA said that Reps.

Certification requirements upped for pharmacy techs

Certification requirements upped for pharmacy techs

With pharmacy’s role in health care delivery expanding, the Pharmacy Technician Certification Board (PTCB) plans to raise its standards for national certification and recertification. PTCB said Wednesday that it will phase in the changes over the next seven years.

Mylan begins shipping Antara generic

Mylan Inc. has released fenofibrate capsules in dosages of 43 mg and 130 mg, used to treat high levels of cholesterol and triglycerides. The company said Monday that the product, rolled out by its Mylan Pharmaceuticals subsidiary, is the generic version of Lupin Atlantis Holdings’ Antara capsules.

Study: Community Rx saves Medicare on 90-day scripts

Compared with mail order pharmacies, community pharmacies provide 90-day prescriptions Medicare Part D beneficiaries at lower cost and substitute less-expensive generic drugs more often, a study sponsored by the National Community Pharmacists Association found.

Index: Customer satisfaction up at drug stores

Index: Customer satisfaction up at drug stores

Chain drug stores were among the retailers seeing more satisfied customers in 2012, according to a report by the American Customer Satisfaction Index (ACSI). ACSI said Tuesday that its national benchmark, which measures customer satisfaction on a scale of 0 to 100, edged up 0.5% to 76.

New CEO to take helm at Endo

Rajiv De Silva has been named president and chief executive officer of Endo Health Solutions. The company said Monday that De Silva, 46, previously president of Valeant Pharmaceuticals, is slated to take the CEO reins starting on March 18. He succeeds David Holveck, who is retiring.